Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
- PMID: 25553994
- DOI: 10.1016/j.jmii.2014.10.006
Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
Abstract
Background/purpose: Identification of risks of mortality for carbapenem-resistant Acinetobacter baumannii (CRAB), with early implementation of an appropriate therapy, is crucial for the patients' outcome. The aim of this study was to survey mortality risk factors in 182 patients with CRAB bacteremia in a medical center in Taiwan.
Methods: A total of 182 isolates of CRAB bacteremia were collected from 2009 to 2012 in Mackay Memorial Hospital, Taipei, Taiwan These isolates were identified by using the genotypic method. Risk of attributable mortality analysis was carried out with a Cox proportional hazards model.
Results: The 182 CRAB isolates belonged to 38 different pulsotypes. The attributable mortality rate of the 182 patients was 58.24%. The risk factors for attributable mortality included intensive care unit stay [hazard ratio (HR): 2.27; p = 0.011], an Acute Physiology and Chronic Health Evaluation II score of >20 (HR: 2.19; p < 0.001), respiratory tract as the origin of bacteremia (HR: 3.40; p < 0.001), and previous use of ceftriaxone (HR: 2.51; p = 0.011). The appropriateness of antimicrobial therapy was 18.87% (20/106) in the mortality group versus 88.16% (67/76) in the survivor group (p < 0.001). The sensitivity of CRAB to colistin was 100% and to tigecycline was 40.11%.
Conclusion: The risk factors for mortality for CRAB included intensive care unit stay, a high Acute Physiology and Chronic Health Evaluation II score, respiratory tract as the origin of bacteremia, and previous use of ceftriaxone. Early implementation of an antimicrobial agent that had the highest in vitro activity against CRAB in patients at risk of CRAB bacteremia and high mortality may improve their outcome.
Keywords: Acinetobacter baumannii, bacteremia; mortality; risk factors.
Copyright © 2014. Published by Elsevier B.V.
Similar articles
-
Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.J Microbiol Immunol Infect. 2012 Oct;45(5):356-62. doi: 10.1016/j.jmii.2011.12.009. Epub 2012 May 9. J Microbiol Immunol Infect. 2012. PMID: 22575430
-
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.Infection. 2010 Jun;38(3):173-80. doi: 10.1007/s15010-010-0008-1. Epub 2010 Mar 12. Infection. 2010. PMID: 20224962
-
OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.Clin Lab. 2015;61(7):741-7. doi: 10.7754/clin.lab.2014.141116. Clin Lab. 2015. PMID: 26299073
-
Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.Expert Rev Anti Infect Ther. 2015 Jun;13(6):769-77. doi: 10.1586/14787210.2015.1032254. Epub 2015 Apr 12. Expert Rev Anti Infect Ther. 2015. PMID: 25865094 Review.
-
Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis.Clin Microbiol Infect. 2014 May;20(5):416-23. doi: 10.1111/1469-0691.12363. Epub 2013 Oct 17. Clin Microbiol Infect. 2014. PMID: 24131374 Review.
Cited by
-
A nomogram for predicting the risk of mortality in patients with acute pancreatitis and Gram-negative bacilli infection.Front Cell Infect Microbiol. 2022 Nov 10;12:1032375. doi: 10.3389/fcimb.2022.1032375. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36439207 Free PMC article.
-
An assessment of burden of hospital-acquired pneumonia among abdominal surgical patients in tertiary university hospital in Serbia: A matched nested case-control study.Front Med (Lausanne). 2022 Dec 9;9:1040654. doi: 10.3389/fmed.2022.1040654. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36569168 Free PMC article.
-
Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia.Open Forum Infect Dis. 2020 Aug 24;7(10):ofaa378. doi: 10.1093/ofid/ofaa378. eCollection 2020 Oct. Open Forum Infect Dis. 2020. PMID: 33072809 Free PMC article.
-
Microbiological characteristics and risk factors on prognosis associated with Acinetobacter baumannii bacteremia in general hospital: A single-center retrospective study.Front Microbiol. 2022 Nov 10;13:1051364. doi: 10.3389/fmicb.2022.1051364. eCollection 2022. Front Microbiol. 2022. PMID: 36439789 Free PMC article.
-
Counter Clinical Prognoses of Patients With Bloodstream Infections Between Causative Acinetobacter baumannii Clones ST191 and ST451 Belonging to the International Clonal Lineage II.Front Public Health. 2019 Aug 16;7:233. doi: 10.3389/fpubh.2019.00233. eCollection 2019. Front Public Health. 2019. PMID: 31475131 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical